The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Metalloproteinases: role in breast carcinogenesis, invasion and metastasis
Open accessAbstract
The matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases. Their primary function is degradation of proteins in the extracellular matrix. Currently, at least 19 members of this family are known to exist. Based on substrate specificity and domain organization, the MMPs can be loosely divided into four main groups: the interstitial collagenases, gelatinases, stromelysins and membrane-type MMPs. Recent data from model systems suggest that MMPs are involved in breast cancer initiation, invasion and metastasis. Consistent with their role in breast cancer progression, high levels of at least two MMPs (MMP-2 and stromelysin-3) have been found to correlate with poor prognosis in patients with breast cancer. Because MMPs are apparently involved in breast cancer initiation and dissemination, inhibition of these proteinases may be of value both in preventing breast cancer and in blocking metastasis of established tumours
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Essential Role for Ectodomain Shedding in Mammalian Development
Peschon, J. J., Slack, J. L., Reddy, P., Stocking, K. L., Sunnarborg, S. W., Lee, D. C., Russell, W. E., Castner, B. J., Johnson, R. S., Fitzner, J. N., et al. (1998) · Science · doi:10.1126/science.282.5392.1281 · Cited by 1,607
Changing views of the role of matrix metalloproteinases in metastasis
Chambers, A. F., & Matrisian, L. M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.17.1260 · Cited by 1,588
The urokinase-type plasminogen activator system in cancer metastasis: A review
Andreasen, P. A., Kjøller, L., Christensen, L., & Duffy, M. J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970703)72:1<1::aid-ijc1>3.0.co;2-z · Cited by 1,546
Self-citationAngiogenesis and Tumor Metastasis
Zetter, B. R. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.407 · Cited by 1,015
Ohuchi, E., Imai, K., Fujii, Y., Sato, H., Seiki, M., & Okada, Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.4.2446 · Cited by 938
The Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary Carcinogenesis
Sternlicht, M. D., Lochter, A., Sympson, C. J., Huey, B., Rougier, J.-P., Gray, J. W., Pinkel, D., Bissell, M. J., & Werb, Z. (1999) · Cell · doi:10.1016/s0092-8674(00)81009-0 · Cited by 924
Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention
Stetler-Stevenson, W. G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6870 · Cited by 842
Matrix Metalloproteinases Regulate Neovascularization by Acting as Pericellular Fibrinolysins
Hiraoka, N., Allen, E., Apel, I. J., Gyetko, M. R., & Weiss, S. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81768-7 · Cited by 712
Furin-dependent intracellular activation of the human stromelysin-3 zymogen
Pei, D., & Weiss, S. J. (1995) · Nature · doi:10.1038/375244a0 · Cited by 629
TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3
Amour, A., Slocombe, P. M., Webster, A., Butler, M., Knight, C. G., Smith, B. J., Stephens, P. E., Shelley, C., Hutton, M., Knäuper, V., et al. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01031-x · Cited by 609
Guedez, L., Stetler-Stevenson, W. G., Wolff, L., Wang, J., Fukushima, P., Mansoor, A., & Stetler-Stevenson, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2881 · Cited by 397
Levi, E., Fridman, R., Miao, H. Q., Ma, Y. S., Yayon, A., & Vlodavsky, I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7069 · Cited by 351
Activity of type IV collagenases in benign and malignant breast disease
Davies, B., Miles, D., Happerfield, L., Naylor, M., Bobrow, L., Rubens, R., & Balkwill, F. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.207 · Cited by 323
Membrane‐type matrix metalloproteinases
SEIKI, M. (1999) · APMIS · doi:10.1111/j.1699-0463.1999.tb01536.x · Cited by 300
Cancer invasion and tissue remodeling‐cooperation of protease systems and cell types
DANØ, K., RØMER, J., NIELSEN, B. S., BJØRN, S., PYKE, C., RYGAARD, J., & LUND, L. R. (1999) · APMIS · doi:10.1111/j.1699-0463.1999.tb01534.x · Cited by 291
Masson, R., Lefebvre, O., Noël, A., Fahime, M. E., Chenard, M.-P., Wendling, C., Kebers, F., LeMeur, M., Dierich, A., Foidart, J.-M., et al. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.6.1535 · Cited by 291
Baker, A. H., George, S. J., Zaltsman, A. B., Murphy, G., & Newby, A. C. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690217 · Cited by 286
Valente, P., Fassina, G., Melchiori, A., Masiello, L., Cilli, M., Vacca, A., Onisto, M., Santi, L., Stetler-Stevenson, W. G., & Albini, A. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980119)75:2<246::aid-ijc13>3.0.co;2-b · Cited by 273
Dong, J., Opresko, L. K., Dempsey, P. J., Lauffenburger, D. A., Coffey, R. J., & Wiley, H. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6235 · Cited by 263
Yoneda, T., Sasaki, A., Dunstan, C., Williams, P. J., Bauss, F., De Clerck, Y. A., & Mundy, G. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119435 · Cited by 247
Codony‐Servat, J., Albanell, J., López-Talavera, J. C., Arribas, J., & Baselga, J. M. (1999) · PubMed · Cited by 238
Matrix metalloproteinase-2 immunoreactive protein: A marker of aggressiveness in breast carcinoma
Talvensaari-Mattila, A., P��kk�, P., H�yhty�, M., Blanco-Sequeiros, G., & Turpeenniemi-Hujanen, T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980915)83:6<1153::aid-cncr14>3.0.co;2-4 · Cited by 217
Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3.
Pei, D., Majmudar, G., & Weiss, S. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47324-3 · Cited by 215
Nemunaitis, J. J., Poole, C. J., Primrose, J. M., et al. (1998) · PubMed · Cited by 211
Sledge, G. W., Qulali, M., Goulet, R., Bone, E. A., & Fife, R. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.20.1546 · Cited by 194
Eccles, S. A., Box, G., Court, W. J., Bone, E. A., Thomas, W., & Brown, P. D. N. (1996) · PubMed · Cited by 191
Wang, M., Liu, Y. E., Greene, J., Sheng, S., Fuchs, A., Rosen, E. M., & Shi, Y. E. (1997) · Oncogene · doi:10.1038/sj.onc.1201245 · Cited by 169
The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis.
Rudolph‐Owen, L. A., Chan, R., Muller, W. J., & Matrisian, L. M. (1998) · PubMed · Cited by 162
Stone, A. L., Kröger, M., & Sang, Q. A. (1999) · Journal of Protein Chemistry · doi:10.1023/a:1020692710029 · Cited by 161
Lochter, A., Srebrow, A., Sympson, C. J., Terracio, N., Werb, Z., & Bissell, M. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.8.5007 · Cited by 152
Murphy, G., Segain, J., O'Shea, M., Cockett, M. I., Ioannou, C., Lefèbvre, O., Chambon, P., & Basset, P. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82276-1 · Cited by 135
Clinical studies with matrix metalloproteinase inhibitors
Brown, P. D. N. (1999) · Apmis · doi:10.1111/j.1699-0463.1999.tb01541.x · Cited by 126
Tissue inhibitors of metalloproteinases (TEMP) in invasion and proliferation
HENRIET, P., Blavier, L., & DeClerck, Y. A. (1999) · Apmis · doi:10.1111/j.1699-0463.1999.tb01533.x · Cited by 123
A single ets-related transcription factor, E1AF, confers invasive phenotype on human cancer cells.
Kaya, M., Yoshida, K., Higashino, F., Mitaka, T., Ishii, S., & Fujinaga, K. (1996) · PubMed · Cited by 118
Talbot, B., & Brown, P. D. N. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00398-x · Cited by 105
Expression and regulation of collagenase‐3 (MMP‐13) in human malignant tumors
Balbı́n, M., Pendás, A. M., Urı́a, J. A., Jiménez, M., Freije, J. M. P., & López-Otı́n, C. (1999) · Apmis · doi:10.1111/j.1699-0463.1999.tb01525.x · Cited by 86
Invasive phenotype of MCF10A cells overexpressing c‐Ha‐ras and c‐erbB‐2 oncogenes
Giunciuglio, D., Culty, M., Fassina, G., Masiello, L., Melchiori, A., Paglialunga, G., Arand, G., Ciardiello, F., Basolo, F., Thompson, E. W., et al. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630612 · Cited by 78
Lochter, A., & Bissell, M. J. (1999) · Apmis · doi:10.1111/j.1699-0463.1999.tb01535.x · Cited by 74
Do proteases play a role in cancer invasion and metastasis?
Duffy, M. J. (1987) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(87)90326-9 · Cited by 67
Self-citationFas-Mediated Apoptosis in Ewing's Sarcoma Cell Lines by Metalloproteinase Inhibitors
Mitsiades, N., Poulaki, V., Leone, A., & Tsokos, M. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.19.1678 · Cited by 51
Transcription factors and breast cancer
Benz, C. C. (1998) · Endocrine Related Cancer · doi:10.1677/erc.0.0050271 · Cited by 28
The Role of Stromelysin-1 in Stromal-Epithelial Interactions and Cancer
Wiesen, J. F., & Werb, Z. (2017) · Enzyme and Protein · doi:10.1159/000468624 · Cited by 20
Cited by
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Reactive oxygen species in cancer
Liou, G.-Y., & Storz, P. (2010) · Free Radical Research · doi:10.3109/10715761003667554 · Cited by 3,382
Genes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922
Reactive oxygen species in tumor progression
Storz, P. (2005) · Frontiers in Bioscience · doi:10.2741/1667 · Cited by 957
Sansone, P., Storci, G., Tavolari, S., Guarnieri, T., Giovannini, C., Taffurelli, M., Ceccarelli, C., Santini, D., Paterini, P., Marcu, K. B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32533 · Cited by 779
Metadata
- Authors
- Duffy, M. J., Maguire, T. M., Hill, A., McDermott, E., & O'Higgins, N.
- Venue
- Breast Cancer Research
- Published
- 2000-08
- Volume
- 2
- Issue
- 4
- Pages
- 252-7
- ISSN
- 1465-5411 (ISSN-L)
- 1465-542X
- OpenAlex
- W1605046409
- Cited by
- 628
- References
- 42
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.